334 related articles for article (PubMed ID: 20238303)
1. Targeting the renin angiotensin system for remission/regression of chronic kidney disease.
Macconi D
Histol Histopathol; 2010 May; 25(5):655-68. PubMed ID: 20238303
[TBL] [Abstract][Full Text] [Related]
2. [The effect of angiotensin-converting enzyme inhibitors on the progression of chronic renal failure].
Bernadet-Monrozies P; Rostaing L; Kamar N; Durand D
Presse Med; 2002 Nov; 31(36):1714-20. PubMed ID: 12467154
[TBL] [Abstract][Full Text] [Related]
3. Dual renin-angiotensin system blockade for nephroprotection.
Ruggenenti P
Nephrol Ther; 2017 Apr; 13 Suppl 1():S43-S45. PubMed ID: 28577742
[TBL] [Abstract][Full Text] [Related]
4. [Nephroprotection by inhibition of the renin-angiotensin system--wish or reality?].
Barnas U; Mayer G
Wien Klin Wochenschr; 1995; 107(1):10-4. PubMed ID: 7871784
[TBL] [Abstract][Full Text] [Related]
5. Update concept of the dual blocking of the renin-angiotensin-aldosteron system. A new therapeutic option?
León Jiménez D; Castilla Guerra L; López Chozas JM; Miramontes González JP
Med Clin (Barc); 2018 Jan; 150(1):33-38. PubMed ID: 28668172
[No Abstract] [Full Text] [Related]
6. Dual renin-angiotensin system blockade for nephroprotection: still under scrutiny.
Gentile G; Remuzzi G; Ruggenenti P
Nephron; 2015; 129(1):39-41. PubMed ID: 25531311
[TBL] [Abstract][Full Text] [Related]
7. Management of renin-angiotensin system blockade in patients with chronic kidney disease under specialist care. Retrospective cross-sectional study.
Tylicki L; Jakubowska A; Lizakowski S; Świetlik D; Rutkowski B
J Renin Angiotensin Aldosterone Syst; 2015 Mar; 16(1):145-52. PubMed ID: 25324423
[TBL] [Abstract][Full Text] [Related]
8. Effect of a triple blockade of the renin-angiotensin-system in recurrent focal segmental glomerulosclerosis after kidney transplantation.
Freiberger V; Amann K; Heemann U; Frank H
Transpl Int; 2009 Nov; 22(11):1110-3. PubMed ID: 19497068
[TBL] [Abstract][Full Text] [Related]
9. Limitations of angiotensin inhibition.
Nobakht N; Kamgar M; Rastogi A; Schrier RW
Nat Rev Nephrol; 2011 Jun; 7(6):356-9. PubMed ID: 21502972
[TBL] [Abstract][Full Text] [Related]
10. Dual renin-angiotensin-aldosterone system inhibition: boon or bust?
Hirsch S
Int J Clin Pract; 2010 Sep; 64(10):1337-40. PubMed ID: 20716140
[No Abstract] [Full Text] [Related]
11. Effects of endothelin receptor antagonism relate to the degree of renin-angiotensin system blockade in chronic proteinuric kidney disease.
Dhaun N; Macintyre IM; Melville V; Lilitkarntakul P; Johnston NR; Goddard J; Webb DJ
Hypertension; 2009 Sep; 54(3):e19-20. PubMed ID: 19652085
[No Abstract] [Full Text] [Related]
12. The renin-angiotensin system and diabetic nephropathy.
Gurley SB; Coffman TM
Semin Nephrol; 2007 Mar; 27(2):144-52. PubMed ID: 17418683
[TBL] [Abstract][Full Text] [Related]
13. Blood pressure, hypertension, RAAS blockade, and drug therapy in diabetic kidney disease.
Yamout H; Lazich I; Bakris GL
Adv Chronic Kidney Dis; 2014 May; 21(3):281-6. PubMed ID: 24780456
[TBL] [Abstract][Full Text] [Related]
14. Comprehensive suppression of the renin-angiotensin-aldosterone system in chronic kidney disease: covering all of the bases.
Weinberger MH; Luft FC
Kidney Int; 2006 Dec; 70(12):2051-3. PubMed ID: 17136130
[TBL] [Abstract][Full Text] [Related]
15. [RAS blockade in diabetic nephropathy. "Early intervention can dramatically decrease loss of function].
Ritz E
MMW Fortschr Med; 2004 Sep; 146(38):12. PubMed ID: 15532423
[No Abstract] [Full Text] [Related]
16. Dual blockade of renin-angiotensin system in primary focal segmental glomerulosclerosis.
Singh A
Nephrol Dial Transplant; 2006 Mar; 21(3):830-1. PubMed ID: 16278255
[No Abstract] [Full Text] [Related]
17. Combined blockade of the renin-angiotensin system with angiotensin-converting enzyme inhibitors and angiotensin II type 1 receptor antagonists.
Azizi M; Ménard J
Circulation; 2004 Jun; 109(21):2492-9. PubMed ID: 15173039
[No Abstract] [Full Text] [Related]
18. Is there added value to adding ARB to ACE inhibitors in the management of CKD?
Cohen DL; Townsend RR
J Am Soc Nephrol; 2009 Aug; 20(8):1666-8. PubMed ID: 18776118
[TBL] [Abstract][Full Text] [Related]
19. Rationale for combination angiotensin receptor blocker and angiotensin-converting enzyme inhibitor treatment and end-organ protection in patients with chronic kidney disease.
Toto R; Palmer BF
Am J Nephrol; 2008; 28(3):372-80. PubMed ID: 18073461
[TBL] [Abstract][Full Text] [Related]
20. Aggressive blood pressure reduction and renin-angiotensin system blockade in chronic kidney disease: time for re-evaluation?
Sarafidis PA; Ruilope LM
Kidney Int; 2014 Mar; 85(3):536-46. PubMed ID: 24048382
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
